Literature DB >> 26683836

Immunohistochemical Analysis of E-Cadherin, p53 and Inhibin-α Expression in Hydatidiform Mole and Hydropic Abortion.

Onur Erol1, Dinç Süren2, Birsel Tutuş2, Tayfun Toptaş3, Ahmet Arda Gökay2, Aysel Uysal Derbent4, Mustafa Kemal Özel4, Cem Sezer2.   

Abstract

The purpose of this study was to investigate the role of E-cadherin, p53, and inhibin-α immunostaining in the differential diagnosis of hydropic abortion (HA), partial hydatidiform mole (PHM), and complete hydatidiform mole (CHM). E-cadherin, p53, and inhibin-α protein expression patterns were investigated immunohistochemically using paraffin -embedded tissue sections from histologically diagnosed cases of HA (n = 23), PHM (n = 24), and CHM (n = 23). Expression patterns of these markers were scored semi-quantitatively according to the staining intensity, percentage of positive cells, and immunoreactivity score. Classification of cases was established on histologic criteria and supported by the molecular genotyping. Immunostaining allowed the identification of specific cell types with E-cadherin, p53, and inhibin-α expression in all cases. E-cadherin expression was detected on the cell surface of villous cytotrophoblasts. We observed a marked decline in the expression of E-cadherin from HAs to PHMs to CHMs. The p53-positive reaction was restricted to the nucleus of villous cytotrophoblasts. Significantly increased p53 expression was observed in CHMs, compared with HAs and PHMs. The expression of inhibin-α was localised in the cytoplasm of villous syncytiotrophoblasts, and the expression of this marker was significantly higher in PHMs and CHMs than HAs. In conclusion, immunohistochemical analysis of E-cadherin, p53, and inhibin-α expression could serve as a useful adjunct to conventional methods in the differential diagnosis of HA, PHM, and CHM.

Entities:  

Keywords:  E-cadherin; Hydatidiform mole; Inhibin-α; p53

Mesh:

Substances:

Year:  2015        PMID: 26683836     DOI: 10.1007/s12253-015-0031-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  33 in total

Review 1.  Molecular interactions at the maternal-embryonic interface during the early phase of implantation.

Authors:  S J Kimber
Journal:  Semin Reprod Med       Date:  2000       Impact factor: 1.303

2.  p53 and Bcl-2 oncoprotein expression in placentas with hydropic changes and partial and complete moles.

Authors:  I A Al-Bozom
Journal:  APMIS       Date:  2000-11       Impact factor: 3.205

Review 3.  Inhibins, activins and follistatin in reproduction.

Authors:  D M de Kretser; M P Hedger; K L Loveland; D J Phillips
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

4.  Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.

Authors:  I M Shih; R J Kurman
Journal:  Int J Gynecol Pathol       Date:  1999-04       Impact factor: 2.762

Review 5.  Inhibin, activin and follistatin in the human placenta--a new family of regulatory proteins.

Authors:  F Petraglia
Journal:  Placenta       Date:  1997-01       Impact factor: 3.481

6.  The diagnostic value of Ki-67, P53 and P63 in distinguishing partial Hydatidiform mole from hydropic abortion.

Authors:  Yunxin Chen; Danhua Shen; Yiqun Gu; Pingping Zhong; Junlin Xie; Qiujin Song
Journal:  Wien Klin Wochenschr       Date:  2012-01-09       Impact factor: 1.704

7.  Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis.

Authors:  Weijie Yuan; Zhikang Chen; Shaobin Wu; Jie Ge; Shi Chang; Xianwei Wang; Jingxiang Chen; Zihua Chen
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

8.  Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study.

Authors:  K Marzusch; P Ruck; H P Horny; J Dietl; E Kaiserling
Journal:  Placenta       Date:  1995-01       Impact factor: 3.481

9.  Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.

Authors:  Mahmoud R Hussein
Journal:  Exp Mol Pathol       Date:  2009-04-05       Impact factor: 3.362

10.  p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.

Authors:  S-Y Jun; J Y Ro; K-R Kim
Journal:  Histopathology       Date:  2003-07       Impact factor: 5.087

View more
  1 in total

1.  High expression of eIF3d is associated with poor prognosis in patients with gastric cancer.

Authors:  Jiaqi He; Xuefei Wang; Jianhua Cai; Wei Wang; Xinyu Qin
Journal:  Cancer Manag Res       Date:  2017-10-25       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.